Please upgrade your browser.
Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer
Medarex, Inc. (Nasdaq: MEDX) today announced it has initiated a Phase 1b clinical trial for MDX-1106 (ONO-4538: development code of Ono Pharmaceutical Co., Ltd.), a fully human anti-PD-1 antibody for the treatment of cancer. Studies suggest that the PD-1 signaling pathway may play an important role in tumor evasion and escape from host immune responses and may also promote the persistence of certain chronic viral infections.
Biotechnology company Antigenics Inc (AGEN.O: Quote, Profile, Research, Stock Buzz) said on Monday that its Oncophage vaccine extended survival in a small study of patients with brain cancer.
A REVOLUTIONARY painless technique that uses electrical pulses to zap tumours is being trialled at The Alfred hospital to treat cancer.
Scientists have identified three genes linked to the body's processing of fats that may increase the risk of kidney cancer.
Despite what his cancer doctors told him 2 1/2 years ago, Joe Daniels still coaches the Buckeyes' quarterbacks
Learn about renal cancers on the ASCO Cancer.net website
Landmark 15-Year Study Of UCLA Kidney Cancer Patients Shows Aggressive, Personalized Therapy Improves Survival
The one-size-fits-all approach traditionally used in kidney cancer treatment should be changed based on the results of the study.
Scientists at the Van Andel Institute made a new discovery while studying two types of kidney cancer.
I am Chair of FROG which is a support group in Oxford for kidney cancer patients.
TroVax cancer vaccine provokes a response in most bowel, kidney and prostate cancer patients who took part in several trials and may prolong lives, a survey found.
|Powered by NeonCRM|